Friday, February 3, 2023

To gain two years of technology life

A type 1 diabetic person lives on a consistent diet, has complete control over his or her glucose levels, does moderate physical exercise, manages his or her daily dose of insulin, and so on. These chronic patients, who are unable to produce insulin on their own, could extend their life expectancy by up to two years, thanks to a Spanish research method and device that has just been published by the main scientific journal specializing in the disease. got support, diabetes care,

“With our system, global monitoring is done by the health team, taking into account all data of interest for good control and management of diabetes”, summarizes Jose Luis López Sanchez-Pascuala, CEO and co-founder of Insulclock. We are talking about the first measurement system that has replaced disposable insulin pens with other pens Smart, linked to an application for smartphones Including all the data, healthcare professionals also have a platform for exclusive use. The latest study on its use also showed that the system “improves glycemic control and well-being in patients with type 2 diabetes, as well as quality of life in patients with type 1 diabetes.” In addition It helps to detect and prevent errors in the administration of insulin through monitoring of forgotten insulin doses, timing and administration”.

CEO of Insulclock, details The system is already implemented in about twenty public hospitals in Murcia, Andalusia, the Basque Country, Castilla León, Madrid, the Canary Islands and Catalonia, such as General de Segovia, October 12, La Paz, Hospital de la Santa Creu. Sant Pau y Virgen de la Arrixaca University Hospital. “Currently, we are conducting various trials nationally and internationally in collaboration with various endocrinology units,” he says. “Our dream is to cover at least the entire national territory for patients with type 1 diabetes in the next two years. We work very hard to reach that reality, because access to this type of technology is essential for everyone Who needs it. This.” By the first and second quarter of 2023, they expect to close their first contracts with public administrations in the four autonomous communities.

We ask him if there is a possibility to acquire the system privately until that moment comes. “Our idea is that no patient has to pay any amount, we work so that access to this new technology for the control and monitoring of diabetes is through the respective Ministries of Health and the respective autonomous communities, the latter being the one who bears the cost. . It’s our mission to make sure everyone has access to technology that helps improve their quality of life and their families with chronic diseases, in this case we’re talking about diabetes. They estimate They are already working on a system like InsulClock that will help ease the pain.

With six million diabetics, Spain is the second country in Europe with the highest number of patients with the disease. As explained by those responsible for InsulClock, the system “significantly reduces the rising cost of health care due to complications primarily due to lack of treatment adherence.” They state that 10% of worldwide health spending is allocated to diabetes and in the case of Spain, the total health cost for this disease is 17,630 million euros per year (23% of total spending on health). And they provide data on the savings achieved with this diabetes monitoring technology, which amounted to 1,550 euros per year for each patient with diabetes, as well as an InsulaCloud 360 telemonitoring system (representing 28% total savings). with a lower number of hospitalizations. and work absenteeism.

Nation World News Desk
Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news